Whilst most reports addressing the impact of TGFβ pathway polymorphisms on side effects of radiotherapy so far are retrospective, a recent study conducted in a prospective fashion highlighted the −509T allele in the promoter region of TGFB1 as a key determinant of breast fibrosis risk [18]. Here, TGFB1 is linked to breast fibrosis.